At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Randomized, Single Dose, Parallel, Triple-blinded Study in Infertile Females to Evaluate Biosimilarity of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA)
In Brief
A Phase 4 clinical trial evaluating Epifasi: Human chorionic gonadotrophin and Pregnyl: Human chorionic gonadotrophin for Infertility, Female. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Comparative randomized, single dose, parallel, triple-blinded study in infertile females to evaluate biosimilarity of IM Injection of Human Chorionic Gonadotrophin (HCG) after Parenteral administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA)
Study Details
Timeline
Interventions
IM Injection of 1 ampoule contains 5000 I.U. of Human chorionic gonadotrophin
IM Injection of 1 ampoule contains 5000 I.U. of Human chorionic gonadotrophin